AT9283
Term · Oncology and biomedicine · MLC-T-ONC-000776
A substance being studied in the treatment of some types of cancer. It blocks enzymes (Aurora kinases) involved in cell division and may kill cancer cells. AT9283 is a type of serine/threonine protein kinase inhibitor. Also called Aurora kinase inhibitor AT9283.
| Identifier | MLC-T-ONC-000776 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | Aurora kinase inhibitor AT9283 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000776",
"term": "AT9283",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of some types of cancer. It blocks enzymes (Aurora kinases) involved in cell division and may kill cancer cells. AT9283 is a type of serine/threonine protein kinase inhibitor. Also called Aurora kinase inhibitor AT9283.",
"expansions": [
"Aurora kinase inhibitor AT9283"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/at9283/"
}
Record 2,536 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.